Literature DB >> 9385923

Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits.

J Nilsson1, F Calara, J Regnstrom, A Hultgardh-Nilsson, S Ameli, B Cercek, P K Shah.   

Abstract

OBJECTIVES: In this study we tested the hypothesis that immunization with homologous oxidized low density lipoprotein (oxLDL) would inhibit the neointimal response to balloon injury in hypercholesterolemic rabbits.
BACKGROUND: Immunization with homologous oxLDL has been shown to markedly reduce aortic atherosclerosis in LDL receptor-deficient as well as cholesterol-fed rabbits; however, the effect of this strategy on the balloon injury-induced neointimal lesion is unknown.
METHODS: New Zealand White rabbits were immunized with 280 microg of homologous native LDL (n = 5), copper-oxidized LDL (n = 5) or phosphate buffer as control (n = 5) and fed a 1% cholesterol diet. Rabbits were reimmunized after 3 weeks, and balloon injury of the right ileofemoral artery was performed 1 week later. Four weeks after balloon injury, rabbits were killed, and the neointimal lesion area was measured by computerized morphometry after perfusion fixation of the arteries. Circulating antibodies against oxLDL were measured by enzyme-linked immunosorbent assay.
RESULTS: In comparison with the control animals, those immunized with oxLDL had a 58% reduction in the neointimal area (0.53 +/- 0.13 vs. 1.27 +/- 0.26 mm2; p = 0.01). The group immunized with native LDL had a 19% reduction in the neointimal area compared with the control group (p = NS). Circulating cholesterol levels and antibody titers against oxLDL were comparable in the three groups. There was a trend toward reduced immunoreactivity for T cells and oxLDL in the neointima of oxLDL-immunized animals.
CONCLUSIONS: Hypercholesterolemic rabbits immunized with homologous oxLDL have a markedly reduced neointimal area after balloon injury despite severe hypercholesterolemia. Together with previous work, these data suggest that an immunization strategy (vaccination) against atherosclerosis and restenosis warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385923     DOI: 10.1016/s0735-1097(97)00366-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.

Authors:  Jillian P Rhoads; Amy S Major
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 3.  Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

Authors:  Kuang-Yuh Chyu; Prediman K Shah
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.

Authors:  Giuseppina Caligiuri; Antonino Nicoletti; Bruno Poirier; Göran K Hansson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 5.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 6.  Natural antibodies and the autoimmunity of atherosclerosis.

Authors:  Christoph J Binder; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

7.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

Authors:  S Hörkkö; D A Bird; E Miller; H Itabe; N Leitinger; G Subbanagounder; J A Berliner; P Friedman; E A Dennis; L K Curtiss; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.

Authors:  S Caspar-Bauguil; J Tkaczuk; M J Haure; M Durand; J Alcouffe; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

Review 9.  The role of the vascular dendritic cell network in atherosclerosis.

Authors:  Noah Alberts-Grill; Timothy L Denning; Amir Rezvan; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

Review 10.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.